Maggiore Christopher D. 13D and 13G filings for ZIVO Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-06-07 9:22 pm Purchase |
2024-06-05 | 13D | ZIVO Bioscience, Inc. ZIVO |
Maggiore Christopher D. | 458,371 14.000% |
103,213![]() (+29.06%) |
Filing |
2024-01-22 5:15 pm Purchase |
2023-12-13 | 13D | ZIVO Bioscience, Inc. ZIVO |
Maggiore Christopher D. | 355,158 12.800% |
191,867![]() (+117.50%) |
Filing |
2023-02-14 08:32 am Purchase |
2023-02-14 | 13D | ZIVO Bioscience, Inc. ZIVO |
Maggiore Christopher D. | 163,291 10.200% |
44,102![]() (+37.00%) |
Filing |